Australia Medical Tubing Market Expected to reach USD 1,177.0 Mn by 2032

The Australia medical tubing market, projected to reach a valuation of USD 652.2 Million in 2025, is set for robust growth. Estimates indicate the market will expand to USD 1,177.0 Million by 2032, registering a CAGR of 8.6% during the forecast period. Key growth drivers include the rising demand for minimally invasive surgical procedures, increased use of tubing in drug delivery systems, and advancements in material technologies such as thermoplastics and silicone. Additionally, the expanding elderly population and the prevalence of chronic diseases are boosting the consumption of catheters, peristaltic pump tubing, and respiratory circuits. Regulatory emphasis on biocompatibility and precision manufacturing, coupled with growing investment in local medtech production capabilities, is further propelling innovation and adoption across Australia's healthcare and diagnostics sectors.

The full report is now available for purchase: https://www.coherentmi.com/industry-reports/australia-medical-tubing-market 

The Australia medical tubing market is experiencing robust growth, driven by the rising demand for minimally invasive surgical procedures, chronic disease management, and the expansion of advanced healthcare infrastructure across the country. Increasing applications of medical tubing in catheters, cannulas, drug delivery systems, and robotic-assisted surgeries are propelling market expansion, especially as precision, biocompatibility, and flexibility become essential design criteria.

On June 5, 2025, Nitinol tubing witnessed a significant uptick in adoption within Australian surgical robotics, following clinical reports highlighting a 40% reduction in operation times. Owing to its superelasticity and shape memory properties, the tubing enables precise navigation during intricate procedures, strengthening its role in next-generation surgical platforms.

Moreover, advancements in materials such as thermoplastics, silicone, and shape-memory alloys like Nitinol are enabling the development of flexible, kink-resistant tubing solutions suited for complex surgical procedures and wearable medical devices. Regulatory bodies such as the Therapeutic Goods Administration (TGA) are placing greater emphasis on the safety, sterilization, and performance of tubing products, which is accelerating investment in cleanroom manufacturing, extrusion technologies, and automated quality control systems.

With growing private and public investments in healthcare R&D, the integration of drug-eluting tubing and smart tubing technologies for targeted delivery and remote monitoring is also gaining traction. As patient-centric care and home-based treatment models evolve, the Australia medical tubing market is well-positioned for sustained growth, underpinned by a shift toward safer, more efficient, and precision-engineered solutions across clinical applications.

The adoption of minimally invasive procedures continues to drive innovation in catheter design, with a growing emphasis on performance, flexibility, and precision for complex vascular access. Companies are increasingly introducing specialized medical tubing solutions that enhance the safety and efficacy of catheter-based interventions.
In December 2024, Terumo Interventional Systems (TIS), a division of Terumo Corporation, announced the U.S. launch of its R2P NaviCross peripheral support catheter. The device, now available in a 200 cm configuration, features a double-braided stainless-steel construction engineered for superior torque control and trackability in radial-to-peripheral procedures. This expansion strengthens Terumo’s R2P portfolio, supporting a broader range of minimally invasive interventions.

Australia’s aging population and rising incidence of chronic diseases such as cardiovascular conditions and diabetes are significantly boosting demand for long-term care medical devices, including catheters, feeding tubes, and dialysis tubing. The increased need for continuous care and home-based treatment options is shaping medical tubing design toward greater durability, flexibility, and biocompatibility.

In December 2024, the Australian Institute of Health & Welfare reported that hospitalizations for dialysis nearly tripled between 2000–01 and 2021–22, reaching 1.7 million dialysis episodes in 2021–22—representing 14% of all hospital stays. This trend underscores the growing reliance on chronic care infrastructure and associated tubing products across Australia's healthcare system.

The growing emphasis on real-time monitoring and precision therapy delivery is creating new opportunities for smart medical tubing integrated with sensors and data-tracking capabilities. These advanced tubes can measure parameters like flow rate, pressure, and temperature—enabling intelligent drug delivery, early leakage detection, and enhanced patient safety, particularly in critical care and home-based infusion therapies.

In April 2024, a team at the University of Newcastle (Australia) unveiled a self-calibrating weighing sensor combined with peristaltic pumps for closed-loop infusion monitoring. This IoT-enabled tubing system can detect infusion volume and flow in real time, with cloud-based dashboards for clinicians.

Rising concerns over global supply chain disruptions—particularly those exacerbated by the COVID-19 pandemic and geopolitical instability—are driving a national pivot toward self-sufficiency in critical healthcare components, including medical tubing. In response, Australian manufacturers are increasingly investing in localized production and R&D focused on advanced materials such as thermoplastic elastomers (TPE), fluoropolymers, polyurethanes, and medical-grade silicones. These materials are essential for meeting the strict safety, flexibility, and biocompatibility standards required in drug delivery, dialysis, catheterization, and robotic surgery applications.

Moreover, there is growing emphasis on environmental compliance, recyclable materials, and the use of bio-based polymers to align with Australia’s circular economy and low-carbon manufacturing goals. Universities, such as the University of New South Wales and RMIT, are collaborating with local medtech firms to accelerate the development of next-generation tubing products that incorporate antimicrobial properties, low extractables/leachables, and smart features like embedded sensors.